Kamada - High Quality Pharmaceuticals
    Portuguese
  Homepage   About us   Products   Capabilities   Clinical Development   Partners   Investor Relations   News & Events   Contact us  
 
Press Releases
Events
Press Kit
    Press Releases
 
2010|2009|2008|2007|2006|

Jan | Feb | Mar | May | Jul | Aug | Sep | Oct | Dec
 
 
Kamada Acquires 1 Additional Acre Intended for Expansion of its Manufacturing Facilities
December 18, 2007
Kamada, a biopharmaceutical company, announces today that it has acquired, through a subsidiary, approximately 1 additional acre in the area adjoining its manufacturing facility in Beit-Kama, intended for future expansion of the company’s manufacturing facilities. The total area owned by Kamad...

Click here to read the full Press Release
 
 
Kamada Receives a US Patent for Transferrin
December 10, 2007
Kamada announced today that it has been granted a US patent for "Ultrapure Transferrin for Pharmaceutical Compositions”. Transferrin is a highly purified human protein which functions as an iron carrier. Kamada Transferrin has potential for utilization in the pharmaceutical industry as a ...

Click here to read the full Press Release
 
 
"Many Alpha-1 Patients Eagerly Anticipate FDA/EMEA Clearance of Kamadas flagship AAT Products"
December 2, 2007
According to Dr. Robert Sandhaus, Clinical Director of the American Alpha-1 Foundation

Weizmann Science Park, Ness Ziona, Israel, December 2nd, 2007. Kamada (TASE: KMDA), a bio-pharmaceutical company, hosted in Tel-Aviv last week, in cooperation with the Israeli Soci...


Click here to read the full Press Release
 
 
    More

Sign up to automatically receive e-mail alerts from Kamada
 
 
All rights reserved to Kamada © 2010 Terms and Conditions | Privacy Policy | Colours